healthy volunteers including prediabetes
Conditions
Interventions
Astaxanthin 12 mg daily for 12 weeks
placebo for 12 weeks
Sponsors
Kamiichi General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Those whose fasting blood glucose is 125 mg / dL or less. 2) Those who can take astaxanthin for 3 months. 3) Those who are between the ages of 20 and 75 at the time of obtaining consent. 4) Those who have received sufficient explanation before participating in this research, and who have obtained the consent of the document by their own free will after sufficient understanding. 5) Those who can be inspected outpatiently. 6) Those who have not taken other health foods or supplements that affect the evaluation of astaxanthin efficacy within one month before the start of the study.
Exclusion criteria
Exclusion criteria: 1) Those who have been diagnosed with diabetes or who have been diagnosed with diabetes. 2) Women who are pregnant or may be pregnant, women who wish to become pregnant, and Lactating woman. 3) Those who are receiving drug therapy at a medical institution. 4) In addition, those who are judged to be inappropriate for this study by the clinical research investigator or the co-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c | — |
Secondary
| Measure | Time frame |
|---|---|
| 75g OGTT,RHI,Lipids | — |
Countries
Japan
Contacts
Public ContactMasaharu Urakaze
Kamiichi General Hospital Medicine
Outcome results
None listed